IPO8 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.151000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.718800E-01
Normal-vs-Stage2
2.039800E-01
Normal-vs-Stage3
5.770200E-02
Normal-vs-Stage4
9.699000E-01
Stage1-vs-Stage2
3.677800E-01
Stage1-vs-Stage3
2.023900E-02
Stage1-vs-Stage4
4.550600E-01
Stage2-vs-Stage3
1.427560E-01
Stage2-vs-Stage4
1.289790E-01
Stage3-vs-Stage4
5.445900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.171200E-01
Normal-vs-AfricanAmerican
3.810600E-01
Normal-vs-Asian
1.453770E-01
Caucasian-vs-AfricanAmerican
7.726800E-01
Caucasian-vs-Asian
3.371800E-01
AfricanAmerican-vs-Asian
4.094200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.760440E-01
Normal-vs-Female
2.914800E-01
Male-vs-Female
1.711390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.969200E-01
Normal-vs-Age(41-60Yrs)
4.434800E-01
Normal-vs-Age(61-80Yrs)
1.411230E-01
Normal-vs-Age(81-100Yrs)
3.056800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.492400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.061800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.512200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.410490E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.737400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.545600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.828500E-02
Normal-vs-Daily Drinker
2.580000E-01
Normal-vs-Weekly Drinker
2.587200E-01
Normal-vs-Occasional Drinker
3.375400E-01
Normal-vs-Social Drinker
6.633600E-01
Non Drinker-vs-Daily Drinker
7.172000E-01
Non Drinker-vs-Weekly Drinker
6.654000E-01
Non Drinker-vs-Occasional Drinker
8.586400E-02
Non Drinker-vs-Social Drinker
3.915600E-02
Daily Drinker-vs-Weekly Drinker
9.451600E-01
Daily Drinker-vs-Occasional Drinker
3.301000E-01
Daily Drinker-vs-Social Drinker
1.865240E-01
Weekly Drinker-vs-Occasional Drinker
3.858600E-01
Weekly Drinker-vs-Social Drinker
2.399200E-01
Occasional Drinker-vs-Social Drinker
5.606600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.018200E-02
Normal-vs-Grade 2
7.724800E-03
Normal-vs-Grade 3
1.208330E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.538200E-01
Grade 1-vs-Grade 3
4.365000E-01
Grade 1-vs-Grade 4
2.018200E-02
Grade 2-vs-Grade 3
4.864100E-02
Grade 2-vs-Grade 4
7.724800E-03
Grade 3-vs-Grade 4
1.208330E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.092240E-01
Normal-vs-NonDiabetic
1.891380E-01
Diabetic-vs-NonDiabetic
3.583600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.947400E-01
Normal-vs-NoPancreatitis
1.704210E-01
Pancreatitis-vs-NoPancreatitis
8.777000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.708800E-01
Normal-vs-N1
2.063800E-01
N0-vs-N1
9.525000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.161400E-01
Normal-vs-TP53-NonMutant
4.672800E-01
TP53-Mutant-vs-TP53-NonMutant
6.448200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
